LCM
PRAH

Laurion Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Laurion Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,500
Closed -$1.07M – 935
2021
Q2 		$1.07M Buy
+6,500
New +$1.09M 0.01% 431
2020
Q1 		– Sell
-16,400
Closed -$1.82M – 1203
2019
Q4 		$1.82M Buy
+16,400
New +$1.69M 0.01% 468
2019
Q2 		– Sell
-12,802
Closed -$1.41M – 1276
2019
Q1 		$1.41M Buy
12,802
+3,851
+43% +$402K 0.02% 457
2018
Q4 		$823K Sell
8,951
-475,164
-98% -$48.1M 0.01% 605
2018
Q3 		$53.3M Buy
+484,115
New +$50.4M 0.52% 21
2018
Q1 		– Sell
-48,190
Closed -$4.39M – 1824
2017
Q4 		$4.39M Sell
48,190
-668,246
-93% -$55.6M 0.02% 554
2017
Q3 		$54.6M Buy
+716,436
New +$54.1M 0.24% 68
2017
Q1 		– Sell
-641,900
Closed -$35.4M – 1648
2016
Q4 		$35.4M Buy
+641,900
New +$35.2M 0.34% 71

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Laurion Capital Management's PRAH Position: Q3 2021 in Review

Laurion Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 6,500 shares — an estimated $1.07M sold.

Laurion Capital Management first reported a position in PRAH in Q4 2016 and held it in 8 quarters. The position peaked at $54.6M in Q3 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Laurion Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Laurion Capital Management sold 6,500 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.07M.
  • Laurion Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 8 quarters.
  • Laurion Capital Management's PRA Health Sciences, Inc. position peaked at $54.6M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Laurion Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.